CN Stock MarketDetailed Quotes

300573 Shenyang Xingqi Pharmaceutical

Watchlist
  • 84.17
  • -0.97-1.14%
Market Closed Dec 13 15:00 CST
14.75BMarket Cap42.34P/E (TTM)

Shenyang Xingqi Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
30.27%1.44B
30.10%891.8M
22.10%349.88M
17.42%1.47B
10.02%1.1B
14.14%685.47M
-5.10%286.56M
21.59%1.25B
30.37%1B
29.89%600.57M
Operating revenue
30.27%1.44B
30.10%891.8M
22.10%349.88M
17.42%1.47B
10.02%1.1B
14.14%685.47M
-5.10%286.56M
21.59%1.25B
30.37%1B
29.89%600.57M
Other operating revenue
----
-18.82%11.61M
----
20.08%27.86M
----
937.96%14.3M
----
544.94%23.2M
----
25.06%1.38M
Total operating cost
23.05%1.11B
18.27%694.36M
19.36%313.25M
18.25%1.2B
18.50%899.95M
30.28%587.09M
22.57%262.44M
28.36%1.01B
31.01%759.48M
25.28%450.65M
Operating cost
25.61%311.14M
20.15%194.73M
21.42%83.61M
24.99%332.06M
24.11%247.7M
33.80%162.07M
15.22%68.86M
17.95%265.67M
20.12%199.58M
14.70%121.13M
Operating tax surcharges
57.42%19.77M
50.56%11.89M
52.81%4.06M
4.95%16.41M
2.85%12.56M
3.25%7.9M
-29.18%2.65M
13.32%15.64M
19.99%12.21M
21.42%7.65M
Operating expense
25.90%516.89M
21.93%331.38M
11.98%150.01M
15.51%535.31M
19.80%410.56M
34.49%271.78M
40.64%133.97M
37.00%463.43M
36.98%342.72M
31.70%202.09M
Administration expense
6.84%120.23M
10.62%78.69M
28.60%38.7M
17.08%154.49M
-6.68%112.53M
-3.05%71.14M
-13.97%30.09M
11.57%131.95M
40.42%120.59M
39.93%73.37M
Financial expense
96.85%-155.63K
70.26%-1.04M
34.45%-1.19M
23.06%-6.23M
18.43%-4.95M
16.26%-3.51M
6.41%-1.82M
-231.94%-8.09M
-220.58%-6.07M
-214.38%-4.19M
-Interest expense (Financial expense)
398.48%4.07M
560.16%2.26M
284.14%605.37K
53.38%1.44M
1.21%815.91K
-43.35%342.7K
-66.48%157.59K
-84.35%937.47K
-82.76%806.19K
-81.86%604.89K
-Interest Income (Financial expense)
19.81%-4.75M
7.64%-3.65M
9.55%-1.85M
20.34%-7.91M
22.84%-5.92M
25.88%-3.95M
24.14%-2.04M
-1,096.03%-9.93M
-1,775.72%-7.68M
-3,757.49%-5.33M
Research and development
14.75%139.48M
1.28%78.7M
32.72%38.07M
14.89%167.3M
34.39%121.55M
53.58%77.71M
28.56%28.68M
64.64%145.61M
45.26%90.45M
32.20%50.6M
Credit Impairment Loss
25.05%-3.27M
20.03%-3.58M
199.72%1.19M
-263.51%-3.73M
-11.89%-4.36M
-121.29%-4.47M
-279.72%-1.19M
-6,298.36%-1.03M
-112.82%-3.9M
-68.59%-2.02M
Asset Impairment Loss
-12.44%-3.1M
32.74%-1.74M
134.36%1.76M
-88.28%-8.29M
-5,545.02%-2.75M
-673.67%-2.58M
-849.64%-5.12M
-17.12%-4.41M
119.89%50.56K
-384.88%-333.79K
Other net revenue
195.14%20.38M
289.58%11.29M
949.02%10.63M
-42.65%8.3M
-11.51%6.9M
-11.54%2.9M
-1,207.11%-1.25M
35.90%14.47M
-16.27%7.8M
24,036.43%3.28M
Invest income
---24.24K
---24.24K
----
----
----
----
----
----
----
----
Asset deal income
421.82%101.67K
589.43%154.62K
----
-108.92%-37.53K
-2,061.53%-31.59K
-2,061.53%-31.59K
----
-91.85%420.75K
-100.03%-1.46K
---1.46K
Other revenue
89.79%26.66M
65.02%16.48M
51.66%7.68M
4.53%20.36M
20.59%14.05M
77.24%9.98M
423.87%5.06M
218.55%19.48M
229.65%11.65M
349.31%5.63M
Operating profit
66.33%352.31M
106.09%208.74M
106.63%47.25M
10.56%276.52M
-16.14%211.82M
-33.89%101.28M
-74.00%22.87M
0.69%250.1M
26.32%252.59M
49.27%153.2M
Add:Non operating Income
189.07%247.33K
-67.57%25.16K
----
-96.84%95.56K
-95.86%85.56K
15.26%77.56K
1,467.82%110.51K
-58.20%3.02M
8,323.83%2.07M
174.05%67.29K
Less:Non operating expense
59.56%14.7M
1.67%8.44M
408.65%5.6M
-40.12%11.62M
-46.44%9.21M
-42.83%8.3M
-50.23%1.1M
60.54%19.41M
130.72%17.2M
296.28%14.52M
Total profit
66.69%337.86M
115.26%200.33M
90.40%41.66M
13.38%264.99M
-14.64%202.69M
-32.93%93.06M
-74.49%21.88M
-4.03%233.72M
23.34%237.46M
40.16%138.75M
Less:Income tax cost
131.32%47.1M
484.20%31M
173.19%6.91M
13.27%24.96M
-41.20%20.36M
-70.71%5.31M
-78.18%2.53M
-36.01%22.03M
48.76%34.63M
64.53%18.12M
Net profit
59.47%290.76M
92.95%169.32M
79.59%34.75M
13.39%240.04M
-10.11%182.33M
-27.25%87.75M
-73.91%19.35M
1.23%211.68M
19.84%202.84M
37.11%120.63M
Net profit from continuing operation
59.47%290.76M
92.95%169.32M
79.59%34.75M
13.39%240.04M
-10.11%182.33M
-27.25%87.75M
-73.91%19.35M
1.23%211.68M
19.84%202.84M
37.11%120.63M
Net profit of parent company owners
59.47%290.76M
92.95%169.32M
79.59%34.75M
13.39%240.04M
-10.11%182.33M
-27.25%87.75M
-73.91%19.35M
8.72%211.68M
29.96%202.84M
50.53%120.63M
Earning per share
Basic earning per share
59.05%1.67
90.20%0.97
75.00%0.28
12.21%1.93
-35.98%1.05
-62.77%0.51
-80.95%0.16
-28.03%1.72
-13.68%1.64
38.38%1.37
Diluted earning per share
59.05%1.67
90.20%0.97
75.00%0.28
12.21%1.93
-35.98%1.05
-62.77%0.51
-80.95%0.16
-27.73%1.72
-13.68%1.64
38.38%1.37
Other composite income
Total composite income
59.47%290.76M
92.95%169.32M
79.59%34.75M
13.39%240.04M
-10.11%182.33M
-27.25%87.75M
-73.91%19.35M
0.98%211.68M
19.84%202.84M
37.11%120.63M
Total composite income of parent company owners
59.47%290.76M
92.95%169.32M
79.59%34.75M
13.39%240.04M
-10.11%182.33M
-27.25%87.75M
-73.91%19.35M
8.43%211.68M
29.96%202.84M
50.53%120.63M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 30.27%1.44B30.10%891.8M22.10%349.88M17.42%1.47B10.02%1.1B14.14%685.47M-5.10%286.56M21.59%1.25B30.37%1B29.89%600.57M
Operating revenue 30.27%1.44B30.10%891.8M22.10%349.88M17.42%1.47B10.02%1.1B14.14%685.47M-5.10%286.56M21.59%1.25B30.37%1B29.89%600.57M
Other operating revenue -----18.82%11.61M----20.08%27.86M----937.96%14.3M----544.94%23.2M----25.06%1.38M
Total operating cost 23.05%1.11B18.27%694.36M19.36%313.25M18.25%1.2B18.50%899.95M30.28%587.09M22.57%262.44M28.36%1.01B31.01%759.48M25.28%450.65M
Operating cost 25.61%311.14M20.15%194.73M21.42%83.61M24.99%332.06M24.11%247.7M33.80%162.07M15.22%68.86M17.95%265.67M20.12%199.58M14.70%121.13M
Operating tax surcharges 57.42%19.77M50.56%11.89M52.81%4.06M4.95%16.41M2.85%12.56M3.25%7.9M-29.18%2.65M13.32%15.64M19.99%12.21M21.42%7.65M
Operating expense 25.90%516.89M21.93%331.38M11.98%150.01M15.51%535.31M19.80%410.56M34.49%271.78M40.64%133.97M37.00%463.43M36.98%342.72M31.70%202.09M
Administration expense 6.84%120.23M10.62%78.69M28.60%38.7M17.08%154.49M-6.68%112.53M-3.05%71.14M-13.97%30.09M11.57%131.95M40.42%120.59M39.93%73.37M
Financial expense 96.85%-155.63K70.26%-1.04M34.45%-1.19M23.06%-6.23M18.43%-4.95M16.26%-3.51M6.41%-1.82M-231.94%-8.09M-220.58%-6.07M-214.38%-4.19M
-Interest expense (Financial expense) 398.48%4.07M560.16%2.26M284.14%605.37K53.38%1.44M1.21%815.91K-43.35%342.7K-66.48%157.59K-84.35%937.47K-82.76%806.19K-81.86%604.89K
-Interest Income (Financial expense) 19.81%-4.75M7.64%-3.65M9.55%-1.85M20.34%-7.91M22.84%-5.92M25.88%-3.95M24.14%-2.04M-1,096.03%-9.93M-1,775.72%-7.68M-3,757.49%-5.33M
Research and development 14.75%139.48M1.28%78.7M32.72%38.07M14.89%167.3M34.39%121.55M53.58%77.71M28.56%28.68M64.64%145.61M45.26%90.45M32.20%50.6M
Credit Impairment Loss 25.05%-3.27M20.03%-3.58M199.72%1.19M-263.51%-3.73M-11.89%-4.36M-121.29%-4.47M-279.72%-1.19M-6,298.36%-1.03M-112.82%-3.9M-68.59%-2.02M
Asset Impairment Loss -12.44%-3.1M32.74%-1.74M134.36%1.76M-88.28%-8.29M-5,545.02%-2.75M-673.67%-2.58M-849.64%-5.12M-17.12%-4.41M119.89%50.56K-384.88%-333.79K
Other net revenue 195.14%20.38M289.58%11.29M949.02%10.63M-42.65%8.3M-11.51%6.9M-11.54%2.9M-1,207.11%-1.25M35.90%14.47M-16.27%7.8M24,036.43%3.28M
Invest income ---24.24K---24.24K--------------------------------
Asset deal income 421.82%101.67K589.43%154.62K-----108.92%-37.53K-2,061.53%-31.59K-2,061.53%-31.59K-----91.85%420.75K-100.03%-1.46K---1.46K
Other revenue 89.79%26.66M65.02%16.48M51.66%7.68M4.53%20.36M20.59%14.05M77.24%9.98M423.87%5.06M218.55%19.48M229.65%11.65M349.31%5.63M
Operating profit 66.33%352.31M106.09%208.74M106.63%47.25M10.56%276.52M-16.14%211.82M-33.89%101.28M-74.00%22.87M0.69%250.1M26.32%252.59M49.27%153.2M
Add:Non operating Income 189.07%247.33K-67.57%25.16K-----96.84%95.56K-95.86%85.56K15.26%77.56K1,467.82%110.51K-58.20%3.02M8,323.83%2.07M174.05%67.29K
Less:Non operating expense 59.56%14.7M1.67%8.44M408.65%5.6M-40.12%11.62M-46.44%9.21M-42.83%8.3M-50.23%1.1M60.54%19.41M130.72%17.2M296.28%14.52M
Total profit 66.69%337.86M115.26%200.33M90.40%41.66M13.38%264.99M-14.64%202.69M-32.93%93.06M-74.49%21.88M-4.03%233.72M23.34%237.46M40.16%138.75M
Less:Income tax cost 131.32%47.1M484.20%31M173.19%6.91M13.27%24.96M-41.20%20.36M-70.71%5.31M-78.18%2.53M-36.01%22.03M48.76%34.63M64.53%18.12M
Net profit 59.47%290.76M92.95%169.32M79.59%34.75M13.39%240.04M-10.11%182.33M-27.25%87.75M-73.91%19.35M1.23%211.68M19.84%202.84M37.11%120.63M
Net profit from continuing operation 59.47%290.76M92.95%169.32M79.59%34.75M13.39%240.04M-10.11%182.33M-27.25%87.75M-73.91%19.35M1.23%211.68M19.84%202.84M37.11%120.63M
Net profit of parent company owners 59.47%290.76M92.95%169.32M79.59%34.75M13.39%240.04M-10.11%182.33M-27.25%87.75M-73.91%19.35M8.72%211.68M29.96%202.84M50.53%120.63M
Earning per share
Basic earning per share 59.05%1.6790.20%0.9775.00%0.2812.21%1.93-35.98%1.05-62.77%0.51-80.95%0.16-28.03%1.72-13.68%1.6438.38%1.37
Diluted earning per share 59.05%1.6790.20%0.9775.00%0.2812.21%1.93-35.98%1.05-62.77%0.51-80.95%0.16-27.73%1.72-13.68%1.6438.38%1.37
Other composite income
Total composite income 59.47%290.76M92.95%169.32M79.59%34.75M13.39%240.04M-10.11%182.33M-27.25%87.75M-73.91%19.35M0.98%211.68M19.84%202.84M37.11%120.63M
Total composite income of parent company owners 59.47%290.76M92.95%169.32M79.59%34.75M13.39%240.04M-10.11%182.33M-27.25%87.75M-73.91%19.35M8.43%211.68M29.96%202.84M50.53%120.63M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Pension Holdings
Pension Holdings
Intraday-1.66%
Pharmaceutical E-commerce
Pharmaceutical E-commerce
Intraday-1.88%